Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Acute sleep deprivation delays the glucagon-like peptide 1 peak response to breakfast in healthy men
At 2 mg per week (the starting dose), one vial provides five doses across five weeks
Current areas of scientific interest include: Multi-receptor metabolic signaling GLP-1 receptor pathway activity GIP receptor function Glucagon receptor signaling Energy expenditure and energy homeostasis Appetite and satiety signaling pathways Glucose and lipid metabolism research Endocrine system integration Technical Specifications Product quantities and handling information should be followed as provided with the supplied material
Substantial Weight Loss Over 68 Weeks Participants who received the highest dose (12 mg) experienced an average 28.7 % reduction in body weight, equivalent to roughly 71.2 lbs from their starting weights over 68 weeks, far greater than the placebo group, which saw about a 2.1 % reduction
GLP-1 receptors are expressed in the mesolimbic reward system, including the ventral tegmental area and nucleus accumbens
GLP-1 ( Glucagon-Like Peptide-1 ) is a hormone secreted by L cells, mainly in the intestine, which: The role of this hormone in regulating appetite makes it a key element in weight-loss therapies
